Chemokine receptors play a prominent role in cancer progression and metastasis. This study investigated whether the expression of CXC chemokine receptor types 4 and 7 (CXCR4 and CXCR7, respectively), determined immunohistochemically, was associated with clinicopathological characteristics and postoperative survival in gallbladder cancer specimens from 72 patients. CXCR4 was detected in the cytoplasm and/or nucleus of gallbladder cancer cells, but CXCR7 was detected only in the cytoplasm. Expression of either CXCR7 or CXCR4 in the cytoplasm was associated with tumour stage. Expression of nuclear CXCR4 was associated with lymph node metastases and lymphatic invasion. Cytoplasmic expression of CXCR4 and CXCR7 were each independent risk factors for worse postoperative survival. Further research is required to clarify the mechanisms involved in these associations and to determine their potential prognostic and therapeutic implications.
MüllerAHomeyBSotoH: Involvement of chemokine receptors in breast cancer metastasis. Nature2001; 410: 50–56.
2.
SchimanskiCCSchwaldSSimiantonakiN: Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res2005; 11: 1743–1750.
3.
SchimanskiCCBahreRGockelI: Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer2006; 95: 210–217.
4.
PhillipsRJBurdickMDLutzM: The stromal derived factor-1/CXCL12–CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med2003; 167: 1676–1686.
5.
AkashiTKoizumiKTsuneyamaK: Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci2008; 99: 539–542.
6.
ShenXArtinyanAJacksonD: Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways. Pancreas2010; 39: 81–87.
7.
EnglTReljaBMarianD: CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia2006; 8: 290–301.
8.
MoriTDoiRKoizumiM: CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther2004; 3: 29–37.
9.
BalabanianKLaganeBInfantinoS: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem2005; 280: 35760–35766.
10.
BurnsJMSummersBCWangY: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med2006; 203: 2201–2213.
11.
MiaoZLukerKESummersBC: CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A2007; 104: 15735–15740.
12.
DonohueJHStewartAKMenckHR: The National Cancer Data Base report on carcinoma of the gallbladder, 1989–1995. Cancer1998; 83: 2618–2628.
13.
GourgiotisSKocherHMSolainiL: Gallbladder cancer. Am J Surg2008; 196: 252–264.
14.
American Joint Committee on Cancer (AJCC): AJCC Cancer Staging Manual, 7th edn.New York: Springer, 2010.
15.
RossiDZlotnikA: The biology of chemokines and their receptors. Annu Rev Immunol2000; 18: 217–242.
16.
SozzaniSMolinoMLocatiM: Receptor-activated calcium influx in human monocytes exposed to monocyte chemotactic protein-1 and related cytokines. J Immunol1993; 150: 1544–1553.
17.
RamanDBaugherPJThuYM: Role of chemokines in tumor growth. Cancer Lett2007; 256: 137–165.
18.
O'HayreMSalangaCLHandelTM: Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J2008; 409: 635–649.
19.
Oliveira-NetoHHSilvaETLelesCR: Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas. Tumour Biol2008; 29: 262–271.
20.
BalkwillF: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol2004; 14: 171–179.
21.
KakinumaTHwangST: Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol2006; 79: 639–651.
22.
ZlotnikA: New insights on the role of CXCR4 in cancer metastasis. J Pathol2008; 215: 211–213.
23.
SignoretNOldridgeJPelchen-MatthewsA: Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol1997; 139: 651–664.
24.
LaptevaNYangAGSandersDE: CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther2005; 12: 84–89.
25.
ShimHLauSKDeviS: Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1α. Biochem Biophys Res Commun2006; 346: 252–258.
26.
LinSYMakinoKXiaW: Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol2001; 3: 802–808.
27.
WooSUBaeJWKimCH: A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer. Ann Surg Oncol2008; 15: 281–285.
28.
WangNWuQLFangY: Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome. J Transl Med2005; 3: 26.
29.
NaIKScheibenbogenCAdamC: Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis. Hum Pathol2008; 39: 1751–1755.
30.
WangSCLinJKWangHS: Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int J Colorectal Dis2010; 25: 1185–1191.
31.
SalvucciOBouchardABaccarelliA: The role of CXCR4 receptor expression in breast cancer: A large tissue microarray study. Breast Cancer Res Treat2006; 97: 275–283.
32.
WagnerPLHyjekEVazquezMF: CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg2009; 137: 615–621.
33.
WangJShiozawaYWangY: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem2008; 283: 4283–4294.
34.
D'AlterioCConsalesCPolimenoM: Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer. Curr Cancer Drug Targets2010; 10: 772–781.
35.
IwakiriSMinoNTakahashiT: Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. Cancer2009; 115: 2580–2593.
36.
HattermannKHeld-FeindtJLuciusR: The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res2010; 70: 3299–3308.
37.
ThelenMThelenS: CXCR7, CXCR4 and CXCL12: an eccentric trio?J Neuroimmunol2008; 198: 9–13.
38.
LukerKEGuptaMSteeleJM: Imaging ligand-dependent activation of CXCR7. Neoplasia2009; 11: 1022–1035.
39.
RajagopalSKimJAhnS: β-Arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7. Proc Natl Acad Sci U S A2010; 107: 628–632.
40.
ZabelBAWangYLewenS: Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol2009; 183: 3204–3211.
PercherancierYBerchicheYASlightI: Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem2005; 280: 9895–9903.
43.
SierroFBibenCMartínez-MuñozL: Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A2007; 104: 14759–14764.
44.
RubinJBKungALKleinRS: A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A2003; 100: 13513–13518.
45.
SmithMCLukerKEGarbowJR: CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res2004; 64: 8604–8612.
46.
BurgerJAPeledA: CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia2009; 23: 43–52.
